Surgepays Financials
SURG Stock | USD 1.75 0.05 2.78% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 2.76 | 2.6263 |
|
|
The essential information of the day-to-day investment outlook for Surgepays includes many different criteria found on its balance sheet. An individual investor should monitor Surgepays' cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Surgepays.
Net Income |
|
Surgepays | Select Account or Indicator |
Understanding current and past Surgepays Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Surgepays' financial statements are interrelated, with each one affecting the others. For example, an increase in Surgepays' assets may result in an increase in income on the income statement.
Surgepays Stock Summary
Surgepays competes with Trust Stamp, Freight Technologies, Versus Systems, Auddia, and Viant Technology. SurgePays, Inc., a financial technology and telecommunications company, provides services to the underbanked community in the United States. Further, it operates a bilingual operations center offering the Company with sales support, customer service, IT infrastructure design, graphic media, database programming, software development, revenue assurance, lead generation, and other various operational support services. Surgepays operates under SoftwareApplication classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.Foreign Associate | Canada |
Specialization | Communication Services, Telecommunication Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US86882L2043 |
CUSIP | 86882L204 86882L105 656846201 50116D107 |
Location | Tennessee; U.S.A |
Business Address | 3124 Brother Boulevard, |
Sector | Wireless Telecommunication Services |
Industry | Communication Services |
Benchmark | Dow Jones Industrial |
Website | surgepays.com |
Phone | 901 302 9587 |
Currency | USD - US Dollar |
Surgepays Key Financial Ratios
Return On Equity | -0.0519 | ||||
Profit Margin | (0.01) % | ||||
Operating Margin | (0.72) % | ||||
Price To Sales | 0.31 X | ||||
Revenue | 137.14 M |
Surgepays Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.0M | 7.3M | 19.5M | 34.0M | 41.9M | 44.0M | |
Other Current Liab | 678.0K | 1.9M | 555.1K | 12.9M | 123.2K | 117.1K | |
Net Debt | 8.2M | 7.0M | 1.4M | 1.1M | (9.2M) | (8.7M) | |
Retained Earnings | (10.9M) | (21.6M) | (35.1M) | (35.8M) | (15.2M) | (14.4M) | |
Accounts Payable | 4.6M | 7.3M | 7.4M | 7.5M | 7.3M | 7.7M | |
Cash | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
Other Current Assets | 1.4M | 172.6B | 5.6K | 111.5K | 161.9K | 153.8K | |
Total Liab | 14.7M | 18.1M | 15.9M | 28.9M | 13.5M | 7.7M | |
Total Current Assets | 3.6M | 1.3M | 13.9M | 27.6M | 33.4M | 35.0M | |
Common Stock | 102.2K | 127.1K | 12.1K | 14.1K | 14.4K | 15.1K | |
Net Receivables | 3.1M | 393.1K | 3.2M | 9.2M | 9.5M | 10.0M | |
Short Term Debt | 1.7M | 5.3M | 1.7M | 2.7M | 4.7M | 4.9M | |
Other Assets | (4K) | 66.5K | 61.5K | 176.9K | 203.4K | 213.5K | |
Long Term Debt | 6.6M | 1.7M | 5.5M | 5.0M | 460.5K | 437.5K | |
Inventory | (172.6B) | 178.3K | 4.4M | 11.2M | 9.0M | 9.5M | |
Intangible Assets | 4.8M | 4.1M | 3.4M | 3.2M | 2.7M | 2.0M | |
Net Tangible Assets | (2.9M) | (10.3M) | (15.7M) | (749.2K) | (674.3K) | (708.0K) | |
Short Long Term Debt | 2.1M | 5.9M | 1.7M | 2.7M | 4.6M | 2.5M | |
Other Liab | 883.6K | 600.5K | 869.9K | 852.0K | 979.8K | 808.9K | |
Net Invested Capital | 4.0M | (3.1M) | 10.7M | 12.7M | 33.3M | 35.0M | |
Net Working Capital | (3.5M) | (14.1M) | 3.9M | 4.1M | 20.7M | 21.7M | |
Capital Stock | 115.9K | 140.9K | 12.3K | 14.1K | 14.4K | 13.7K |
Surgepays Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 227.0K | 3.4M | 7.5M | 2.0M | 596.0K | 1.1M | |
Operating Income | (6.8M) | (8.4M) | (6.0M) | 873.7K | 18.9M | 19.8M | |
Ebit | (6.8M) | (6.8M) | (6.2M) | 873.7K | 19.0M | 19.9M | |
Ebitda | (7.0M) | (5.4M) | (5.2M) | 1.9M | 20.1M | 21.1M | |
Income Before Tax | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 18.4M | 19.3M | |
Net Income | (8.2M) | (16.9M) | (18.8M) | (148.9K) | 20.6M | 21.6M | |
Income Tax Expense | (229.0K) | 6.2M | 5.3M | (404.4K) | (2.3M) | (2.2M) | |
Total Revenue | 25.7M | 54.4M | 51.1M | 121.5M | 137.1M | 144.0M | |
Gross Profit | 5.4M | 2.5M | 6.2M | 13.5M | 35.6M | 37.4M | |
Cost Of Revenue | 20.3M | 51.9M | 44.9M | 108.1M | 101.5M | 106.6M | |
Net Interest Income | (227.0K) | (3.4M) | (7.5M) | (2.0M) | (596.0K) | (625.8K) |
Surgepays Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | (98.6K) | 328.0K | 5.6M | 752.2K | 7.6M | 8.0M | |
Free Cash Flow | (6.8M) | (4.3M) | (15.3M) | 94.7K | 10.0M | 10.5M | |
Other Non Cash Items | 505.2K | (628.2K) | 2.2M | 26.1M | 4.7M | 2.9M | |
Capital Expenditures | 227.6K | 6.6K | 51.4K | 698.6K | 281.3K | 295.4K | |
Net Income | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 20.6M | 21.6M | |
End Period Cash Flow | 346.0K | 674.0K | 6.3M | 7.0M | 14.6M | 15.4M | |
Change To Inventory | 2.1M | (178.3K) | (4.3M) | (6.9M) | 2.1M | 2.2M | |
Depreciation | 282.9K | 1.4M | 917.5K | 988.7K | 1.1M | 1.2M | |
Investments | (32.2K) | 15.0K | (376.7K) | (1.5M) | (281.3K) | (295.4K) | |
Net Borrowings | 3.3M | 4.1M | 2.2M | 1.5M | 1.7M | 1.5M |
Surgepays Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Surgepays's current stock value. Our valuation model uses many indicators to compare Surgepays value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Surgepays competition to find correlations between indicators driving Surgepays's intrinsic value. More Info.Surgepays is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . At this time, Surgepays' Return On Equity is most likely to slightly decrease in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Surgepays by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Surgepays Systematic Risk
Surgepays' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Surgepays volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Beta measures systematic risk based on how returns on Surgepays correlated with the market. If Beta is less than 0 Surgepays generally moves in the opposite direction as compared to the market. If Surgepays Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Surgepays is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Surgepays is generally in the same direction as the market. If Beta > 1 Surgepays moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Surgepays Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Surgepays' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Surgepays growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Surgepays November 25, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Surgepays help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Surgepays. We use our internally-developed statistical techniques to arrive at the intrinsic value of Surgepays based on widely used predictive technical indicators. In general, we focus on analyzing Surgepays Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Surgepays's daily price indicators and compare them against related drivers.
Downside Deviation | 5.19 | |||
Information Ratio | (0.02) | |||
Maximum Drawdown | 25.51 | |||
Value At Risk | (8.74) | |||
Potential Upside | 10.26 |
Complementary Tools for Surgepays Stock analysis
When running Surgepays' price analysis, check to measure Surgepays' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgepays is operating at the current time. Most of Surgepays' value examination focuses on studying past and present price action to predict the probability of Surgepays' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgepays' price. Additionally, you may evaluate how the addition of Surgepays to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing |